(VIANEWS) – Lexington Realty Trust (LXP), PIMCO California Municipal Income Fund III (PZC), Pimco Global Stocksplus & Income Fund (PGP) are the highest payout ratio stocks on this list.
We have congregated information about stocks with the highest payout ratio so far. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Lexington Realty Trust (LXP)
631.25% Payout Ratio
Lexington Realty Trust (NYSE: LXP) is a publicly traded real estate investment trust (REIT) that owns a diversified portfolio of real estate assets consisting primarily of equity investments in single-tenant net-leased commercial properties across the United States. Lexington seeks to expand its industrial portfolio through build-to-suit transactions, sale-leaseback transactions and other transactions, including acquisitions.
Earnings Per Share
As for profitability, Lexington Realty Trust has a trailing twelve months EPS of $0.08.
PE Ratio
Lexington Realty Trust has a trailing twelve months price to earnings ratio of 108.25. Meaning, the purchaser of the share is investing $108.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.54%.
Volume
Today’s last reported volume for Lexington Realty Trust is 1808020 which is 22.61% below its average volume of 2336470.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.3%, now sitting on 340.5M for the twelve trailing months.
2. PIMCO California Municipal Income Fund III (PZC)
360.45% Payout Ratio
PIMCO California Municipal Income Fund III is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. It is co-managed by Pacific Investment Management Company LLC. The fund invests in fixed income markets. It seeks to invest in stocks of companies operating across diversified sectors. Its investment portfolio include California municipal bonds, and other municipal bonds and notes; California variable rate notes and other variable rate notes; California variable rate demand notes and other variable rate demand notes; U.S. treasury bills; and call options written and put options written. PIMCO California Municipal Income Fund III was formed on October 31, 2002 and is domiciled in United States.
Earnings Per Share
As for profitability, PIMCO California Municipal Income Fund III has a trailing twelve months EPS of $0.11.
PE Ratio
PIMCO California Municipal Income Fund III has a trailing twelve months price to earnings ratio of 70.82. Meaning, the purchaser of the share is investing $70.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.65%.
Yearly Top and Bottom Value
PIMCO California Municipal Income Fund III’s stock is valued at $7.79 at 20:23 EST, under its 52-week high of $8.20 and way higher than its 52-week low of $6.30.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 9, 2024, the estimated forward annual dividend rate is 0.35 and the estimated forward annual dividend yield is 4.54%.
Volume
Today’s last reported volume for PIMCO California Municipal Income Fund III is 61264 which is 0.22% above its average volume of 61126.
3. Pimco Global Stocksplus & Income Fund (PGP)
97.41% Payout Ratio
PIMCO Global Stocksplus & Income Fund is a closed ended balanced mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It invests in fixed income and public equity markets across the globe. The fund uses a long/short strategy to invest in securities by using financial derivatives such as options. It invests in mortgage-related, government, corporate and other debt securities of U.S. and non-U.S. issuers and emerging market bonds. The fund invests in investment grade securities with a low- to intermediate-average duration. It invests in stocks of companies across diversified sectors. PIMCO Global Stocksplus & Income Fund was formed on April 30, 2003 and is domiciled in the United States.
Earnings Per Share
As for profitability, Pimco Global Stocksplus & Income Fund has a trailing twelve months EPS of $0.85.
PE Ratio
Pimco Global Stocksplus & Income Fund has a trailing twelve months price to earnings ratio of 9.04. Meaning, the purchaser of the share is investing $9.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.75%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 9, 2024, the estimated forward annual dividend rate is 0.83 and the estimated forward annual dividend yield is 10.77%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 11.75M for the twelve trailing months.
Moving Average
Pimco Global Stocksplus & Income Fund’s value is above its 50-day moving average of $7.45 and higher than its 200-day moving average of $7.11.
4. Cardinal Health (CAH)
79.27% Payout Ratio
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Earnings Per Share
As for profitability, Cardinal Health has a trailing twelve months EPS of $2.52.
PE Ratio
Cardinal Health has a trailing twelve months price to earnings ratio of 43.89. Meaning, the purchaser of the share is investing $43.89 for every dollar of annual earnings.
Volume
Today’s last reported volume for Cardinal Health is 1830450 which is 21.31% below its average volume of 2326270.
Moving Average
Cardinal Health’s worth is higher than its 50-day moving average of $106.31 and way above its 200-day moving average of $96.65.
Sales Growth
Cardinal Health’s sales growth for the next quarter is 9.9%.
Previous days news about Cardinal Health (CAH)
- According to Zacks on Friday, 15 March, "Some better-ranked stocks from the broader medical space are Stryker Corporation (SYK Quick QuoteSYK – Free Report) , Cencora, Inc. (COR Quick QuoteCOR – Free Report) and Cardinal Health (CAH Quick QuoteCAH – Free Report) ."
- According to Zacks on Friday, 15 March, "Some better-ranked stocks in the broader medical market sector are DaVita (DVA Quick QuoteDVA – Free Report) , Cardinal Health (CAH Quick QuoteCAH – Free Report) and ICON (ICLR Quick QuoteICLR – Free Report) . ", "While DaVita sports a Zacks Rank #1 (Strong Buy) at present, Cardinal Health and ICON carry a Zacks Rank #2 (Buy) each. "
5. Tiptree (TIPT)
60.61% Payout Ratio
Tiptree Inc., through its subsidiaries, underwrites and administers specialty insurance products primarily in the United States. It operates in two segments, Insurance and Mortgage. The company provides niche commercial and personal lines insurance, credit insurance and collateral protection products, and warranty and service contract products and solutions, as well as premium finance services. It also offers mortgage loans for institutional investors; and maritime transportation services, as well as invests in securities and other assets. Tiptree Inc. markets its products through a network of independent insurance agents, consumer finance companies, auto dealers, retailers, brokers, and managing general agencies. The company was formerly known as Tiptree Financial Inc. and changed its name to Tiptree Inc. in December 2016. Tiptree Inc. was incorporated in 2007 and is based in New York, New York.
Earnings Per Share
As for profitability, Tiptree has a trailing twelve months EPS of $0.33.
PE Ratio
Tiptree has a trailing twelve months price to earnings ratio of 51.21. Meaning, the purchaser of the share is investing $51.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.21%.
Yearly Top and Bottom Value
Tiptree’s stock is valued at $16.90 at 20:23 EST, way below its 52-week high of $20.80 and way above its 52-week low of $12.12.
Moving Average
Tiptree’s value is below its 50-day moving average of $18.30 and higher than its 200-day moving average of $16.60.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
